
    
      To determine tissue pharmacology of a single dose of doxycycline for STI PEP, investigators
      at Emory University will collaborate with the Centers for Disease Control and Prevention
      (CDC) to conduct a clinical trial of up to 20 MSM and women aged 18-59, with measurement of
      anti-retroviral drug and doxycycline concentrations in the rectum and vaginal regions.
    
  